RXO (RXO) Stock Forecast, Price Target & Predictions
RXO Stock Forecast
RXO stock forecast is as follows: an average price target of $23.70 (represents a -15.21% downside from RXO’s last price of $27.95) and a rating consensus of 'Buy', based on 26 wall street analysts offering a 1-year stock forecast.
RXO Price Target
The average price target for RXO (RXO) is $23.70 based on 1-year price targets from 26 Wall Street analysts in the past 3 months, with a price target range of $33.00 to $15.00. This represents a potential -15.21% downside from RXO's last price of $27.95.
RXO Analyst Ratings
According to 26 Wall Street analysts, RXO's rating consensus is 'Buy'. The analyst rating breakdown for RXO stock is 1 'Strong Buy' (3.85%), 14 'Buy' (53.85%), 7 'Hold' (26.92%), 4 'Sell' (15.38%), and 0 'Strong Sell' (0.00%).
RXO Price Target by Analyst
| Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
|---|---|---|---|---|---|---|
| Oct 08, 2024 | Ariel Rosa | Citigroup | $33.00 | $27.62 | 19.48% | 18.07% |
| Sep 26, 2024 | Bascome Majors | Susquehanna | $16.00 | $27.88 | -42.61% | -42.75% |
| Sep 17, 2024 | Scott Schneeberger | Oppenheimer | $31.00 | $25.96 | 19.41% | 10.91% |
| Sep 11, 2024 | Stephanie Moore | Jefferies | $31.00 | $25.26 | 22.72% | 10.91% |
| Jul 08, 2024 | Daniel Imbro | Stephens | $25.00 | $26.77 | -6.61% | -10.55% |
| Jun 25, 2024 | Bruce Chen | Stifel Nicolaus | $26.00 | $24.81 | 4.80% | -6.98% |
| Jun 24, 2024 | Stephanie Moore | Jefferies | $30.00 | $24.85 | 20.72% | 7.33% |
| Jun 20, 2024 | Tom Wadewitz | UBS | $22.00 | $20.06 | 9.67% | -21.29% |
| Apr 11, 2024 | Scott Group | Wolfe Research | $15.00 | $21.38 | -29.84% | -46.33% |
| Jun 09, 2023 | Bascome Majors | Susquehanna | $20.00 | $21.88 | -8.59% | -28.44% |
The latest RXO stock forecast, released on Oct 08, 2024 by Ariel Rosa from Citigroup, set a price target of $33.00, which represents a 19.48% increase from the stock price at the time of the forecast ($27.62), and a 18.07% increase from RXO last price ($27.95).
RXO Price Target by Period
| 1M | 3M | 12M | |
|---|---|---|---|
| # Anlaysts | 1 | 4 | 9 |
| Avg Price Target | $33.00 | $27.75 | $25.44 |
| Last Closing Price | $27.95 | $27.95 | $27.95 |
| Upside/Downside | 18.07% | -0.72% | -8.98% |
In the current month, the average price target of RXO stock is $33.00, according to 1 Wall Street analyst offering twelve months forecast. The average price target represents a 18.07% increase as opposed to RXO's last price of $27.95. This month's average price target is up 18.92% compared to last quarter, and up 29.72% compared to last year.
Analyst Ratings Upgrades/Downgrades
| Date | Company | Previous Rating | New Rating | Rating Change |
|---|---|---|---|---|
| Oct 09, 2024 | Wolfe Research | Underperform | Underperform | Hold |
| Oct 08, 2024 | Citigroup | Neutral | Buy | Initialise |
| Sep 26, 2024 | Susquehanna | Negative | Negative | Hold |
| Sep 17, 2024 | Oppenheimer | Outperform | Outperform | Hold |
| Sep 11, 2024 | Jefferies | Buy | Buy | Hold |
| Aug 15, 2024 | Susquehanna | Negative | Negative | Hold |
| Aug 12, 2024 | Morgan Stanley | Equal-Weight | Equal-Weight | Hold |
| Aug 09, 2024 | Barclays | Overweight | Overweight | Hold |
| Aug 08, 2024 | Cowen & Co. | Hold | Hold | Hold |
| Aug 08, 2024 | Oppenheimer | Outperform | Outperform | Hold |
RXO's last stock rating was published by Wolfe Research on Oct 09, 2024. The company gave RXO a "Underperform" rating, the same as its previous rate.
RXO Financial Forecast
RXO Revenue Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - | - | - | - | $976.00K | $963.00K | $1.01B | $1.12B | $1.14B |
| Avg Forecast | $1.94B | $1.81B | $1.74B | $1.70B | $1.01B | $956.19M | $934.14M | $929.50M | $996.33M | $957.88M | $1.01B | $1.07B | $1.18B | $1.14B |
| High Forecast | $1.94B | $1.81B | $1.74B | $1.70B | $1.01B | $1.01B | $934.14M | $929.50M | $1.01B | $994.97M | $1.01B | $1.07B | $1.18B | $1.14B |
| Low Forecast | $1.94B | $1.81B | $1.74B | $1.70B | $1.01B | $900.60M | $934.14M | $929.50M | $973.30M | $911.89M | $1.01B | $1.07B | $1.18B | $1.14B |
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 5 | 13 | 6 | 6 | 5 | 5 |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.00% | 0.00% | 0.95% | 0.95% | 1.00% |
RXO's average Quarter revenue forecast for Dec 23 based on 5 analysts is $996.33M, with a low forecast of $973.30M, and a high forecast of $1.01B. RXO's average Quarter revenue forecast represents a 101983.35% increase compared to the company's last Quarter revenue of $976.00K (Sep 23).
RXO EBITDA Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 5 | 13 | 6 | 6 | 5 | 5 |
| EBITDA | - | - | - | - | - | - | - | - | - | $747.00K | $737.00K | $23.00M | $24.00M | $50.00M |
| Avg Forecast | $93.40M | $87.26M | $83.63M | $81.91M | $48.80M | $46.01M | $44.95M | $44.73M | $47.94M | $46.09M | $48.80M | $51.42M | $56.63M | $54.90M |
| High Forecast | $93.40M | $87.26M | $83.63M | $81.91M | $48.80M | $48.62M | $44.95M | $44.73M | $48.66M | $47.88M | $48.80M | $51.42M | $56.63M | $54.90M |
| Low Forecast | $93.40M | $87.26M | $83.63M | $81.91M | $48.80M | $43.33M | $44.95M | $44.73M | $46.83M | $43.88M | $48.80M | $51.42M | $56.63M | $54.90M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.02% | 0.02% | 0.45% | 0.42% | 0.91% |
5 analysts predict RXO's average Quarter EBITDA for Dec 23 to be $47.94M, with a high of $48.66M and a low of $46.83M. This is 6317.83% upper than RXO's previous annual EBITDA (Sep 23) of $747.00K.
RXO Net Income Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 5 | 13 | 6 | 6 | 5 | 5 |
| Net Income | - | - | - | - | - | - | - | - | - | $-1.00K | $3.00K | - | $-4.00M | $13.00M |
| Avg Forecast | $29.60M | $24.05M | $16.67M | $8.38M | $10.94M | $5.30M | $3.07M | $-4.48M | $4.66M | $997.19K | $9.32M | $7.94M | $27.25M | $28.79M |
| High Forecast | $29.60M | $24.05M | $16.67M | $8.38M | $10.94M | $7.96M | $3.08M | $-4.48M | $6.21M | $2.99M | $9.32M | $7.94M | $27.25M | $28.79M |
| Low Forecast | $29.60M | $24.05M | $16.67M | $8.38M | $10.94M | $3.98M | $3.06M | $-4.48M | $3.10M | $-3.99M | $9.32M | $7.94M | $27.25M | $28.79M |
| Surprise % | - | - | - | - | - | - | - | - | - | -0.00% | 0.00% | - | -0.15% | 0.45% |
RXO's average Quarter net income forecast for Sep 23 is $997.19K, with a range of $-3.99M to $2.99M. RXO's average Quarter net income forecast represents a 33139.57% increase compared to the company's last Quarter net income of $3.00K (Jun 23).
RXO SG&A Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 5 | 13 | 6 | 6 | 5 | 5 |
| SG&A | - | - | - | - | - | - | - | - | - | $148.00K | $144.00K | $153.00M | $195.00M | $181.00M |
| Avg Forecast | $265.49M | $248.05M | $237.73M | $232.84M | $138.72M | $130.79M | $127.77M | $127.13M | $136.28M | $131.02M | $138.71M | $146.15M | $160.98M | $156.06M |
| High Forecast | $265.49M | $248.05M | $237.73M | $232.84M | $138.72M | $138.20M | $127.77M | $127.13M | $138.33M | $136.09M | $138.71M | $146.15M | $160.98M | $156.06M |
| Low Forecast | $265.49M | $248.05M | $237.73M | $232.84M | $138.72M | $123.18M | $127.77M | $127.13M | $133.13M | $124.73M | $138.71M | $146.15M | $160.98M | $156.06M |
| Surprise % | - | - | - | - | - | - | - | - | - | 0.00% | 0.00% | 1.05% | 1.21% | 1.16% |
RXO's average Quarter SG&A projection for Dec 23 is $136.28M, based on 5 Wall Street analysts, with a range of $133.13M to $138.33M. The forecast indicates a 91978.47% rise compared to RXO last annual SG&A of $148.00K (Sep 23).
RXO EPS Forecast
| Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| # Analysts | 4 | 3 | 7 | 4 | 4 | 9 | 7 | 4 | 5 | 13 | 6 | 6 | 5 | 5 |
| EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-0.03 | $0.11 |
| Avg Forecast | $0.25 | $0.20 | $0.14 | $0.07 | $0.09 | $0.05 | $0.03 | $-0.04 | $0.04 | $0.01 | $0.08 | $0.07 | $0.23 | $0.24 |
| High Forecast | $0.25 | $0.20 | $0.14 | $0.07 | $0.09 | $0.07 | $0.03 | $-0.04 | $0.05 | $0.03 | $0.08 | $0.07 | $0.23 | $0.24 |
| Low Forecast | $0.25 | $0.20 | $0.14 | $0.07 | $0.09 | $0.03 | $0.03 | $-0.04 | $0.03 | $-0.03 | $0.08 | $0.07 | $0.23 | $0.24 |
| Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -0.15% | 0.45% |
According to 5 Wall Street analysts, RXO's projected average Quarter EPS for Dec 22 is $0.23, with a low estimate of $0.23 and a high estimate of $0.23. This represents a 110.69% increase compared to RXO previous annual EPS of $0.11 (Sep 22).
RXO Peer Comparison by Price Target
| Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
|---|---|---|---|---|---|
| HTLD | Heartland Express | $10.90 | $16.33 | 49.82% | Hold |
| MRTN | Marten Transport | $15.90 | $22.50 | 41.51% | Hold |
| ODFL | Old Dominion Freight Line | $203.99 | $271.44 | 33.07% | Hold |
| ARCB | ArcBest | $100.54 | $128.80 | 28.11% | Hold |
| KNX | Knight-Swift Transportation | $53.07 | $59.40 | 11.93% | Buy |
| WERN | Werner Enterprises | $37.31 | $41.67 | 11.69% | Sell |
| SNDR | Schneider National | $28.57 | $27.75 | -2.87% | Buy |
| RXO | RXO | $27.95 | $23.70 | -15.21% | Buy |
| ULH | Universal Logistics | $43.56 | $36.00 | -17.36% | - |
| SAIA | Saia | $486.14 | $376.29 | -22.60% | Buy |
RXO Forecast FAQ
Is RXO a good buy?
Yes, according to 26 Wall Street analysts, RXO (RXO) is considered a 'Buy'. The rating consensus is based on 1 'Strong Buy' and 14 'Buy' recommendations, accounting for 57.69% of RXO's total ratings.
What is RXO's price target?
RXO (RXO) average price target is $23.7 with a range of $15 to $33, implying a -15.21% from its last price of $27.95. The data is based on 26 Wall Street analysts who provided a twelve-month price target estimate in the last three months.
Will RXO stock go up soon?
According to Wall Street analysts' prediction for RXO stock, the company can go down by -15.21% (from the last price of $27.95 to the average price target of $23.7), up by 18.07% based on the highest stock price target, and down by -46.33% based on the lowest stock price target.
Can RXO stock reach $40?
RXO's average twelve months analyst stock price target of $23.7 does not support the claim that RXO can reach $40 in the near future.
What is RXO's current price target trend?
1 Wall Street analyst forecast a $33 price target for RXO (RXO) this month, up 18.07% from its last price of $27.95. Compared to the last 3 and 12 months, the average price target decreased by -0.72% and decreased by -8.98%, respectively.
What are RXO's analysts' financial forecasts?
RXO's analysts financial forecasts for the fiscal year (Dec 2024) are as follows: average revenue is $3.83B (high $3.89B, low $3.78B), average EBITDA is $184.48M (high $187.09M, low $181.81M), average net income is $14.84M (high $17.5M, low $13.51M), average SG&A $524.41M (high $531.82M, low $516.81M), and average EPS is $0.126 (high $0.149, low $0.115). RXO's analysts financial forecasts for the fiscal year (Dec 2025) are as follows: average revenue is $7.19B (high $7.19B, low $7.19B), average EBITDA is $346.2M (high $346.2M, low $346.2M), average net income is $78.7M (high $78.7M, low $78.7M), average SG&A $984.11M (high $984.11M, low $984.11M), and average EPS is $0.669 (high $0.669, low $0.669).
Did the RXO's actual financial results beat the analysts' financial forecasts?
Based on RXO's last annual report (Dec 2022), the company's revenue was $4.8B, beating the average analysts forecast of $2.32B by 106.91%. Apple's EBITDA was $222M, beating the average prediction of $111.53M by 99.04%. The company's net income was $92M, beating the average estimation of $56.04M by 64.16%. Apple's SG&A was $724M, beating the average forecast of $317.04M by 128.36%. Lastly, the company's EPS was $0.8, beating the average prediction of $0.477 by 67.84%. In terms of the last quarterly report (Sep 2023), RXO's revenue was $976K, missing the average analysts' forecast of $957.88M by -99.90%. The company's EBITDA was $747K, missing the average prediction of $46.09M by -98.38%. RXO's net income was $-1K, missing the average estimation of $997.19K by -100.10%. The company's SG&A was $148K, missing the average forecast of $131.02M by -99.89%. Lastly, the company's EPS was $0, missing the average prediction of $0.00848 by -100.00%